Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry

NCT01729455 · clinicaltrials.gov ↗

COMPLETED

Status

3138

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: Benlysta
OTHER: Standard of Care (SoC) Therapy

Sponsor

GlaxoSmithKline